Promoter methylation changes and vascular dysfunction in pre-eclamptic umbilical vein.

Area of Science:

• Obstetrics and Gynecology
• Fetal Medicine
• Vascular Biology

Background:

• Pre-eclampsia is a leading cause of hypertension in pregnancy.
• Vascular dysfunction is a hallmark of pre-eclampsia, but its fetal implications are not well understood.
• This study investigates the impact of pre-eclampsia on fetal blood vessels using human umbilical cord veins.

Purpose of the Study:

• To investigate the pathological changes in fetal vascular function in pre-eclampsia.
• To explore the molecular mechanisms underlying vascular dysfunction in pre-eclamptic fetuses.
• To identify potential epigenetic modifications affecting fetal blood vessels.

Main Methods:

• Utilized human umbilical cord veins from pre-eclamptic and normal pregnancies.
• Assessed vasoconstriction responses to arginine vasopressin (AVP) and oxytocin (OXT).
• Analyzed gene and protein expression of AVP receptor 1a (AVPR1a), oxytocin receptor (OXTR), and protein kinase C isoform β (PKCβ).
• Investigated DNA methylation patterns in the promoter regions of AVPR1a, OXTR, and PKCB.

Main Results:

• Reduced vasoconstriction responses to AVP and OXT were observed in pre-eclamptic umbilical veins.
• Expression of AVPR1a, OXTR, and PKCβ was downregulated in pre-eclamptic umbilical veins.
• Increased DNA methylation in the promoter regions of AVPR1a, OXTR, and PKCB was associated with their reduced expression.

Conclusions:

• This study is the first to demonstrate hyper-methylation in gene promoters, leading to reduced AVPR1a, OXTR, and PKCβ expression in pre-eclamptic umbilical veins.
• Epigenetic modifications, specifically DNA methylation, play a crucial role in the decreased vascular sensitivity to AVP and OXT in pre-eclampsia.
• Findings provide new insights into the pathophysiology of pre-eclampsia-induced fetal vascular dysfunction and the role of epigenetic regulation.